Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

J. Taieb; J. Tabernero; E. Mini; Fabien Subtil; G. Folprecht; Jl. van Laethem; J. Thaler; J. Bridgewater; Ln. Peterson; H. Blons; L. Collette; E. van Cutsem; P. Rougier; R. Salazar; L. Bedenne; Jf. Emile; P. Laurent-Puig; C. Lepage

Journal articles

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

J. Taieb J. Tabernero E. Mini Fabien Subtil ¹ G. Folprecht Jl. van Laethem J. Thaler J. Bridgewater Ln. Peterson H. Blons L. Collette E. van Cutsem P. Rougier R. Salazar L. Bedenne Jf. Emile P. Laurent-Puig C. Lepage

1 Biostatistiques santé

Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadata

https://hal-univ-lyon1.archives-ouvertes.fr/hal-02045524
Contributor : Laure-Hélène Davoine Connect in order to contact the contributor
Submitted on : Friday, February 22, 2019 - 10:41:00 AM
Last modification on : Tuesday, July 20, 2021 - 5:20:07 PM

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

Identifiers

Collections

Citation

Export

Metrics

19

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

Identifiers

Collections

Citation

Export

Share

Metrics

19